Having identified the ability to deliver a mucolytic agent, promote mucociliary clearance, and reverse AHR in a mouse model of allergic asthma, findings reported here support the concept that mucin disulfide disruption could be applied to human lung pathologies where mucus dysfunction is significant7,8. The gene discussed is MUC5AC; the disease is allergic asthma.